Educational Intervention for Healthy Subjects

Research Sponsored by Thomas Jefferson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
With or without a personal or family history of PCA
Be older than 18 years old
Must not have
Be younger than 18 years old
Screening 3 weeks
Treatment Varies
Follow Upbaseline up to 2 months
Awards & highlights
No Placebo-Only Group

Study Summary

This trial is studying how well a peer-based health education program works in reducing barriers to prostate cancer genetic screening in African American participants.

Eligible Conditions
  • Healthy Subjects
  • Prostate Cancer

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
Whether or not you or your family has a history of prostate cancer.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to 2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline up to 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Awareness of risks and benefits of genetic testing
Change in of decisional conflict
Genetic testing
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (health education)Experimental Treatment2 Interventions
Participants attend 1-2 monthly peer educator-led education sessions about PCA genetic testing over 3 hours each for 18 months.
Group II: Arm II (cancer educational materials)Active Control2 Interventions
Participants receive mailed informational materials about PCA risk, family history, and genetic testing.

Find a site

Who is running the clinical trial?

Thomas Jefferson UniversityLead Sponsor
428 Previous Clinical Trials
138,698 Total Patients Enrolled

Media Library

Educational Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05011799 — N/A
Healthy Subjects Research Study Groups: Arm I (health education), Arm II (cancer educational materials)
Healthy Subjects Clinical Trial 2023: Educational Intervention Highlights & Side Effects. Trial Name: NCT05011799 — N/A
Educational Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05011799 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What qualifications are necessary for participants to be accepted into this research project?

"To qualify for this medical study, participants must demonstrate general health and fall within the acceptable age range of 35 to 69. Currently 176 people have been accepted as candidates."

Answered by AI

What is the scope of patient recruitment for this clinical trial?

"Affirmative. provides evidence that this medical trial is actively recruiting for 176 subjects at 1 location, with the original post date being January 8th 2020 and the most recent update happening on August 14th 2023."

Answered by AI

Do adults aged 55 and over qualify for this trial?

"This particular study is reserved for those aged 35 to 69. For younger patients, there are 123 different trials available and 1715 more exist for seniors above the age of 65."

Answered by AI

Are there any available openings for participants in this research study?

"Correct. Per the information accessible on, this medical study is actively recruiting patients and opened for enrollment on January 8th 2020 with its most recent update being dated August 14th 2023. The trial currently has 176 participants enrolled at a single medical centre."

Answered by AI
~29 spots leftby Jul 2024